Background: New techniques, such as those based on multiplex quantitative real-time PCR (MRT-PCR), can improve the detection of invasive candidiasis (IC).
Introduction
In recent years, the incidence of bloodstream infections due to Candida spp. has increased in both adult and paediatric patients. 1 About 30% -50% of all episodes of candidaemia in hospitals occur in patients admitted to the intensive care unit (ICU), and mortality can reach 50%. 2 -5 Data from autopsy-proven cases of invasive candidiasis (IC) and other forms of deep-seated candidiasis suggest that the sensitivity of blood culture remains inadequate. 6 -8 Moreover, several studies have consistently shown that a delay of 12 -48 h in the administration of appropriate antifungal therapy is associated with a significant increase in all-cause mortality that is not related to other mortality risk factors. 9 -11 Alternative strategies for the diagnosis of IC in ICU patients are necessary owing to the low sensitivity of empirical and culture-based antifungal therapy. These approaches include targeted prophylaxis 12 and early treatment based on clinical scores such as the 'Candida score'. 13, 14 The use of empirical antifungal treatment for high-risk patients is prevalent, leading to increased costs and adverse ecological effects. In recent years, different techniques have been proposed as an alternative to microbiological culture. 15 -23 The b-D-glucan (BDG) Fungitell Assay (Associates of Cape Cod Incorporated, Falmouth, MA, USA) was approved by the US FDA as an adjunct in the diagnosis of deep-seated mycoses. Although not Candida-specific, the assay has proven to be a promising tool for the diagnosis of IC. 15 In a recent meta-analysis of 16 studies involving 2979 patients (594 with proven and probable invasive fungal infection), serum BDG was effective in detecting patients with invasive fungal infection with a pooled sensitivity of 76.8% and a pooled specificity of 85.3%. 16 The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline for the diagnosis and management of Candida diseases 2012 recommended the BDG test for detection of candidaemia in adults and considered it very useful for ruling out infection. 8 The detection of Candida albicans germ tube antibody (CAGTA; Candida albicans IFA IgG w , Vircell, Granada, Spain) has also been widely used. Preliminary studies showed a sensitivity of 84.4% and a specificity of 94.7%, even in patients with negative blood cultures. 17 Two studies showed a significant decrease in mortality in ICU patients, especially in those with increasing CAGTA values that had been treated with antifungals. 18, 19 Finally, PCR assays have been developed for the detection of Candida spp. in clinical samples of patients at risk of IC, such as critically ill patients. Fungus-specific PCR assays targeting regions of the 5.8S, 18S and 28S rRNA genes, as well as internal transcribed spacer (ITS) regions, have been evaluated for use with serum or blood samples from various patient groups. Several reports have been published 20 -23 and their pooled sensitivity and specificity were calculated at .85% in a meta-analysis. 23 An interesting feature of real-time PCR is the possibility of detecting multiple targets (multiplex PCR) as new machines incorporate four to six different detection channels. This technique incorporates probes with different fluorophores but similar hybridization conditions. Consequently, it can simultaneously detect multiple targets in a single reaction, thus reducing the time and cost of performing the reactions separately.
The present study is the result of a collaborative research project between the Mycology Service of the Spanish National Microbiology Center and the Ramó n y Cajal Hospital in Madrid. The objectives of this study were to evaluate and validate a new multiplex quantitative real-time PCR (MRT-PCR) for the early detection of IC in clinical samples from critically ill patients and to compare this technique with blood culture, BDG and CAGTA.
Methods
The study was conducted prospectively between January 2010 and June 2012 with funding from the 'Fondo de Investigaciones Sanitarias' (Health Research Fund) of the Spanish Ministry of Health (FIS grant, PS09/01528). The institutional review board approved the study protocol and informed consent was obtained from the patients or their representatives.
The study population comprised ICU patients with clinically suspected IC and no prior antifungal treatment. Before antifungal treatment was started (day 0), blood samples were obtained for culture and whole blood samples and serum were obtained for MRT-PCR. These determinations were repeated in samples obtained on days +2, +7, +14 and +21 or until patients were discharged or died. In addition, BDG and CAGTA were determined in serum samples obtained at days 0 and +7 (and in some cases completed with samples from day +2).
The control group comprised ICU patients with suspected IC in whom IC was discarded and 40 healthy individuals (medical and auxiliary personnel), from whom a single blood sample was obtained and processed for blood culture, Candida PCR, BDG and CAGTA.
Sera and blood cultures were tested blind. With the exception of blood cultures, which were processed immediately, the remaining samples were frozen at 2808C until processed. Blood cultures were processed at the Microbiology Department of Ramon y Cajal Hospital using the BACTEC FX blood culture system (Becton Dickinson Diagnostic Instrument Systems, MD, USA). Fungi were identified using mass spectrometry [matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF), Bruker, Germany] and by PCR of the ITS regions in order to confirm identifications by MALDI-TOF with scores lower than 2.0.
The MRT-PCR assay was performed to detect the six most frequent species of the genus Candida in IC. The technique detected Candida albicans, Candida parapsilosis, Candida tropicalis, Candida glabrata, Candida krusei and Candida guilliermondii using specific molecular beacon probes labelled with different fluorescent dyes: FAM, HEX, ROX and CYAN 500. Primers and probes were designed on the basis of the nucleotide sequences of the ITS ribosomal DNA region from strains belonging to the collection of the Spanish National Center of Microbiology. The probes targeted the ITS1 or ITS2 regions of ribosomal DNA. These regions were chosen as targets because of the possibility of designing a suitable probe for each case. Beacon Designer 5.0 software (Premier Biosoft, Palo Alto, CA, USA) was used to design primers and probes. The assay consisted of two multiplex PCRs: reaction 1 (C. albicans, C. parapsilosis and C. tropicalis), which was performed using the LightCycler Probes Master Kit (Roche Diagnostic, Madrid, Spain); and reaction 2 (C. glabrata, C. krusei and C. guilliermondii), which was performed using the 2x Sensimix Probe Kit (Quantace, Ecogen, Madrid, Spain).
Both PCRs were performed simultaneously in the LightCycler 480 System (Roche Diagnostics, Mannheim, Germany). DNA from blood and sera was extracted using the QIAamp DNA Mini Kit (Qiagen, Izasa, Madrid, Spain). Elution was performed with 50 mL of buffer; the PCR was performed with 2 mL of DNA extracted from each sample. All samples were performed in duplicate and quantification standards were run in conjunction with each set of samples and negative controls.
BDG was performed using the Fungitell w Assay in Fontlab2000 (Barcelona, Spain) and results ≥80 pmol/mL were considered positive. A CAGTA assay was performed in the Microbiology Service of Hospital La Fe (Valencia, Spain) and a serum titre ≥1/160 in at least one sample was considered a positive result. Clinical and laboratory variables were obtained for all patients following a pre-established protocol.
A diagnosis of IC was confirmed based on one of the following criteria: (i) the presence of candidaemia in a patient with consistent clinical manifestations; (ii) isolation of Candida spp. from normal sterile body fluids or peritoneal fluid; only cultures obtained through drainage were considered for diagnosis if samples were obtained at the time of placing the drainage; (iii) ophthalmic examination consistent with Candida endophthalmitis in a patient with clinical sepsis; or (iv) histologically documented candidiasis. 24 Mucosal candidiasis in the absence of clinical and microbiological signs of IC was not considered IC. Colonization was defined as the recovery of Candida species from non-sterile sites (including drainages, see above), independently of the presence of symptoms or signs of systemic disease that were attributable to IC. The Pittet Candida colonization index (number of positive cultures/number of obtained cultures) was obtained and a systematic sample was taken in all patients to calculate the colonization index.
Statistical analysis
Sensitivity, specificity and predictive values were calculated in four settings: (i) IC; (ii) candidaemia; (iii) deep-seated candidiasis; and (iv) IC in highly colonized patients (Pittet index ≥0.5). Healthy controls were included in all the analyses except the analysis of highly colonized patients. Although no surveillance cultures were available, a low grade of colonization was suspected in the healthy controls. The McNemar x 2 test was used to compare sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) between the assays. The univariate analysis of contingency data was performed using a x 2 test or Fisher exact test. The analyses were performed using IBM w SPSS w Statistics version 19 (IBM w , Armonk, NY, USA).
Results
We invited 71 ICU patients with suspected IC to participate in the study before starting antifungal treatment. The first eight patients enrolled were excluded because their samples were obtained through venous catheters that had been implanted for several days and the preliminary results of PCR included a high number PCR for detection of candidiasis in ICU patients 3135 JAC of false positives (catheter contamination). From this time, all samples were obtained through direct venipuncture. Therefore, the study sample comprised the remaining 63 patients.
A diagnosis of IC was confirmed in 27 of the 63 patients included in the study. Of these, 21 developed candidaemia. The other six patients had deep-seated (abdominal or urological) IC. The source of candidiasis in the 27 patients with IC was catheterrelated candidaemia (16 cases) and deep-seated infection (11 cases, with associated candidaemia in 5). IC was not reported in the remaining 36 patients and an alternative diagnosis was confirmed. Table 1 shows the characteristics of the study patients. No differences were found between IC and non-IC patients with regard to APACHE score or predisposing factors such as diabetes, renal failure, type of immunosuppression, antibiotics, parenteral nutrition, Candida score or mortality. Significant differences were only observed for the degree of mucosal colonization by Candida spp. (96% versus 64%, P ¼ 0.002) and for the Pittet index (0.50 versus 0.34, P¼0.013).
Of the 27 patients with IC, 21 had positive blood cultures on day 0 (sensitivity 78%). The time to positivity of the blood culture in this study was 48 h. Ten remained positive on day +2 and 4 on day +7. Candidaemia was not confirmed in any patient on day +14 or +21. Candidaemia was not confirmed on day +2 if blood cultures were sterile on day 0.
MRT-PCR confirmed a positive result in 26 of the 27 patients with IC (sensitivity, 96%). The result was positive on day 0 in 22 patients (sensitivity of MRT-PCR at day 0 ¼ 81.4%). A deferred positive MRT-PCR result was recorded in four patients: three patients on day +7, one patient with negative blood cultures (sensitivity of MRT-PCR at day +7 ¼ 92.5%), and one patient on day +14, with negative blood cultures (sensitivity of MRT-PCR at day +14 ¼ 96%). PCR results that were positive on day 0 remained positive on days +2, +7 and +14, in nine, six and three patients, respectively. No positive MRT-PCR results were observed on day +21 for any patient. A concordance of 100% was detected between the species isolated in blood cultures and MRT-PCR results. In the case of one patient with proven candidaemia by C. parapsilosis, MRT-PCR confirmed C. parapsilosis on days 0, +2 and +7, although MRT-PCR was also positive for C. albicans on day 0. Two positive MRT-PCR results were detected among the 36 patients without IC (false-positive rate¼ 5.5%).
MRT-PCR was performed in both serum and whole blood. For 14/26 of the patients with proven IC, MRT-PCR was positive in both specimens; for the remaining 12 patients, MRT-PCR was positive only in serum (6 patients) and blood (6 patients). The sensitivity of PCR was 77% in whole blood and serum.
The distribution of the Candida species for the 21 patients with candidaemia was as follows: C. albicans, n ¼ 11; C. parapsilosis, n¼ 7; and C. glabrata, n¼ 3. The species confirmed by PCR in the remaining six cases of IC were C. albicans (n ¼ 5) and C. tropicalis (n¼ 1).
BDG and CAGTA were performed in samples obtained on days 0 and +7 in the 63 ICU patients. Of the 27 patients with IC, BDG showed a positive result (≥80 pg/mL) in 22 (81%) and CAGTA was positive in 20 (74%). On the other hand, the rates of falsepositive results for BDG and CAGTA among the 36 patients without IC were 22.2% (8/36) and 38.9% (14/36), respectively.
Blood cultures and PCR were negative in all 40 healthy controls. By contrast, a high rate of false-positive results was confirmed for BDG (5 cases, 12%) and CAGTA (19 cases, 47.5%). Table 2 shows the sensitivity, specificity and predictive values of all four techniques (blood culture, MRT-PCR, BDG and CAGTA) for IC, candidaemia, deep-seated candidiasis and IC in highly colonized patients. For IC, deep-seated candidiasis and candidaemia, the control group included all patients admitted to the ICU where IC was finally discarded and healthy volunteers. To calculate the performance of the tests in cases of IC among highly colonized patients, the control group excluded patients admitted to the ICU with a Pittet index ,0.5 and all healthy volunteers. The most relevant comparative results are stated below. Fortú n et al.
MRT-PCR versus blood culture
The combination of both techniques confirmed the diagnosis of IC in 100% of cases. If candidaemia was considered the gold standard for the diagnosis of fungal infection, the specificity and PPV for the MRT assay were 97.3% and 90.9%, respectively. The sensitivity of the MRT-PCR for the diagnosis of IC was 96.3% overall and .90% in the subgroups (candidaemia, deep-seated candidiasis and highly colonized patients). The size of the series probably prevented differences in sensitivity for blood culture being observed overall (96.3% versus 77.7%, P ¼ 0.10), but MRT-PCR showed a clear trend towards superiority in the deep-seated candidiasis subgroup (90.9% versus 45.4%, P ¼ 0.06).
MRT-PCR versus BDG
The sensitivity of BDG was not significantly lower than that of MRT-PCR (P ¼0.7). BDG revealed a high number of false positives (12% in healthy controls and 22% in ICU patients), thus explaining the significantly lower PPV of BDG than MRT-PCR (and blood cultures) overall and in the subgroups.
MRT-PCR versus CAGTA
The sensitivity for CAGTA was no higher than 75% for any of the settings. The frequency of false positives for the CAGTA assay was 47.5% in healthy controls and 39% in ICU patients. Specificity and PPV for the CAGTA assay were significantly lower than for MRT-PCR (and blood cultures).
Blood cultures were negative in 6 of the 27 patients with IC who were enrolled. Table 3 shows the characteristics of these six patients. They all had abdominal collections and Candida spp. was documented. A favourable response was documented for all except one patient, who died (necropsy not performed). IC was ruled out in two patients with a positive PCR result (falsepositive MRT-PCR; Table 4 ).
Discussion
MRT-PCR has a promising role in the management of ICU patients with suspected IC. The MRT-PCR assay analysed in this study performed better than blood culture; however, differences were not This lower effectiveness of blood culture for the diagnosis of deep-seated IC has been confirmed in other studies. 6, 25 Deep-seated IC is characterized by a low fungal load and short duration of candidaemia, thus explaining the low sensitivity of blood culture in this setting. However, under these conditions, Candida DNA may be released continuously into the bloodstream. 6, 25 A very important finding of this study is the superiority of MRT-PCR over BDG and CAGTA, especially in terms of specificity and PPV. The high sensitivity of BDG has been confirmed elsewhere and it has even been shown to be higher than that of blood culture 15, 16, 26 and other biomarkers (e.g. mannan antigen, anti-mannan Candida antigen and antibody). 27 However, the major limitation of BDG is the large number of false positives it generates, even if two positive determinations are required. Elevated concentrations of BDG have been associated with other fungi (such as Pneumocystis jirovecii), Gram-positive and Gram-negative bloodstream infections, exposure to gauze or other materials that contain glucans, biofilms on vascular catheters, haemodialysis and administration of intravenous immunoglobulin, albumin, coagulation factors and plasma protein fractions. 24, 28 In the present series, the PPV of BDG was only 62.8% overall and 35.0% in deep-seated IC. BDG (Fungitell w ) ≥80 pg/mL was shown to have a PPV of only 30% in a population of 65 ICU patients, of whom 5 developed IC; 28 however, as in other studies, determination of BDG itself was useful for monitoring the response in patients with IC. 29 CAGTA has also been used to optimize the management of IC in the ICU. 17 -19 Leó n et al. 24 recently compared BDG and CAGTA for discriminating between Candida colonization and IC in patients with severe abdominal conditions. The probability of having IC was only 6.1% in patients with BDG concentrations ,259 pg/mL and negative CAGTA results. In a setting with a 30% prevalence of IC, BDG .259 pg/mL and a positive CAGTA result, the authors found the sensitivity to be 90.3%. In the present study, the specificity and PPV of CAGTA were very low owing to the high number of false positives (47.5% in healthy volunteers and 39% in ICU patients). This finding, together with the low sensitivity confirmed in the study (≤75%), makes it difficult to apply CAGTA as a diagnostic tool in these patients.
As regards the most appropriate clinical sample for DNA amplification, in this study whole blood and serum presented similar results, but sensitivity increased if both samples were used in combination. Nguyen et al. 6 showed that the sensitivity of PCR on plasma and serum was superior to that of whole blood, a finding that has also been confirmed elsewhere. 30, 31 The authors suggest that their observation probably reflects an absence of PCR inhibitors, less cumbersome DNA extraction methods and easier detection of cell-free fungal DNA within plasma or sera than whole blood. However, the meta-analysis by Avni et al. 23 showed a higher sensitivity with whole blood than with serum samples and found that serum and blood performed equally well. Thus, serum appears to be the better haematological clinical sample for detection of Candida DNA, since it is easier to process than whole blood. Fortú n et al.
Quantification of biomarkers seems to be the best strategy for both early detection of infection and reduction of empirical treatments. The 2012 ESCMID guideline for the diagnosis and management of Candida diseases recommends determination of some biomarkers (e.g. BDG and mannan) to rule out infection and reduce the prophylactic and empirical misuse of antifungal compounds. 8 In this study MRT-PCR had a sensitivity of 96%, but sensitivity on day 0 was reduced to 81.4% and sensitivity on day 7 was 92.5%. Considering the high NPV of MRT-PCR (93.3% -98.7%) and in order to choose an optimal strategy to reduce empirical therapy in these patients, a possible recommendation would be to start antifungal therapy in cases of suspected IC and remove antifungal therapy if MRT-PCR remains negative in a second determination ( 7 days later). If serum has been used for RT-PCR on day 0 and the result is negative, according to the results of this study and in order to increase the NPV of the test, whole blood can be recommended for a second MRT-PCR determination.
A recent meta-analysis examined the yield of PCR techniques applied directly to blood samples in the diagnosis of IC. 23 More than 4600 patients were analysed in 54 studies using standard PCR, nested PCR and real-time PCR. When controls were patients at risk for IC, sensitivity and specificity values were 93% and 95%, respectively. In this meta-analysis, the sensitivity of blood cultures in the diagnosis of IC was only 38%. Nguyen et al. 6 recently evaluated the role of PCR and BDG in patients with IC. A speciesspecific TaqMan real-time PCR assay was used with alignments of available ITS1 and/or ITS2 sequences for five Candida species (C. albicans, C. glabrata, C. krusei, C. tropicalis and C. parapsilosis complex). The sensitivity of PCR (serum or plasma) was higher than that of BDG and blood culture for the diagnosis of IC. Alam et al. 32 compared the detection of mannan, anti-mannan antibodies, BDG and a semi-nested PCR in patients with cultureproven or suspected candidaemia, women with C. albicans vaginitis and healthy controls. In candidaemia (culture-proven or clinically suspected), the positivity of the tests was 53% for PCR, 29% for BDG, 16% for mannan and 29% for anti-mannan antibodies. 32 The present study also shows the superior performance of the PCR-based technique in comparison with blood cultures and BDG, mainly for deep-seated candidiasis. The results confirm the clinical utility of PCR-based assays to detect and rule out infection. Prospective clinical studies including external validation and harmonization of assays should be performed before recommendations can be made; however, the excellent performance of PCR-based approaches seems to make them very useful clinical tools.
PCR-based Candida detection is subject to limitations in clinical practice. First, MRT-PCR is highly sensitive and susceptible to contamination. The original protocol did not include the mode of obtaining samples. However, after analysis of the MRT-PCR results obtained in the first patients, a large number of species were amplified. This issue was related to a possible colonization/contamination of catheter connections (hub), most of them implanted for several days. This feature is relevant and must be emphasized because it affects the accuracy of the PCR and other authors did not consider this limitation previously. Indeed, this issue is related to the inclusion of healthy controls who were not carriers of catheters. The original design included only ICU controls in whom IC had been discarded. However, the above finding and the possibility of false positives in patients with colonization of the catheters PCR for detection of candidiasis in ICU patients 3139 JAC made us more demanding in our analysis. Therefore, a second population that did not comprise carriers of catheters and whose samples had been obtained from direct venipuncture was included. In fact, the work analyses the different techniques and MRT-PCR in both settings (Table 2) : including only ICU controls (last column of Table 2 ) and including all controls (the rest of the columns). The yields of MRT-PCR are similar, once guaranteed that samples for MRT-PCR analysis were obtained from direct venipuncture, regardless of the type of control used. Second, no gold standard is available for the diagnosis of IC. In the current study, the criteria applied in the definition of IC were very strict and had been validated in rigorous studies. 24 Third, in the absence of candidaemia, it is not easy to demonstrate the presence of IC and it is not easy to rule out IC in highly colonized patients with refractory fever. Colonization is generally accepted as the principal factor limiting the specificity of PCR. 23 Although colonization was significantly higher in the group of patients with IC in the present series, the degree of colonization was also very high (64%) in patients without IC and all but two had a negative PCR result. Finally, this MRT-PCR assay detects C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. krusei and C. guilliermondii. The recent CANDIPOP population-based study conducted in 29 Spanish hospitals collected a total of 781 isolates (from 767 patients, 14 of them having mixed fungaemia) during 2010 and 2011. The species found most frequently were C. albicans (44.6%), C. parapsilosis (24.5%), C. glabrata (13.2%), C. tropicalis (7.6%), C. krusei (1.9%) and C. guilliermondii (1.7%). 33 All of these species could be detected using the MRT-PCR assay. In addition, Candida lusitaniae (1.3%) and other Candida and non-Candida species accounting for 5% of the isolates in the CANDIPOP study would not be likely to be diagnosed by this test.
In conclusion, our results show MRT-PCR to be a very effective tool for the management of IC in critically ill patients. Although blood cultures remain an irreplaceable diagnostic procedure owing to their specificity, ease of use and efficiency, MRT-PCR can serve as a complementary diagnostic assay, thus reducing the disproportionate use of empirical treatment without affecting mortality. Further multicentre clinical studies are warranted, as is external validation of PCR-based assays.
